Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Taiwan
/
Pharmaceuticals & Biotech
Create a narrative
Bora Pharmaceuticals Community
TWSE:6472 Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
Bora Pharmaceuticals
Popular
Undervalued
Overvalued
Community Investing Ideas
Bora Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
US Facility Modernization Will Secure Future Specialty Success
Key Takeaways Strategic shift to high-value CDMO services and facility upgrades has improved margins, driven growth, and positioned the company for market share gains. Operational excellence, regulatory strength, and a focus on U.S. manufacturing enhance customer retention, pricing power, and long-term growth amid stable sector demand.
View narrative
NT$1.00k
FV
18.1% undervalued
intrinsic discount
20.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
6472
6472
Bora Pharmaceuticals
Your Fair Value
NT$
Current Price
NT$820.00
37.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
48b
2015
2018
2021
2024
2025
2027
2030
Revenue NT$48.3b
Earnings NT$13.8b
Advanced
Set Fair Value